Optimization of iontophoretic transdermal delivery of a peptide and a non-peptide drug
- 31 July 1994
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 30 (3), 253-261
- https://doi.org/10.1016/0168-3659(94)90031-0
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- In vivo transdermal iontophoretic delivery of growth hormone releasing factor GRF (1–44) in hairless guinea pigsJournal of Controlled Release, 1992
- Effect of Iontophoresis on In Vitro Skin Permeation of an Analogue of Growth Hormone Releasing Factor in the Hairless Guinea Pig ModelJournal of Pharmaceutical Sciences, 1992
- (D) Routes of delivery: Case studies: (6) Transdermal delivery of peptides and proteinsAdvanced Drug Delivery Reviews, 1992
- Iontophoretic delivery of amino acids and amino acid derivatives across the skin in vitro.Pharmaceutical Research, 1991
- Transdermal Lontophoresis of Gonadotropin Releasing Hormone (Lhrh) and Two AnaloguesJournal of Pharmaceutical Sciences, 1990
- Direct Current Iontophoretic Transdermal Delivery of Peptide and Protein DrugsJournal of Pharmaceutical Sciences, 1989
- Successful transdermal administration of therapeutic doses of a polypeptide to normal human volunteersClinical Pharmacology & Therapeutics, 1988
- Transdermal Iontophoretic Delivery of Therapeutic Peptides/Proteins I: InsulinAnnals of the New York Academy of Sciences, 1987
- New iontophoretic transdermal administration of the beta-blocker metoprololJournal of Controlled Release, 1986
- Comparison Between the Lontophoretic and Passive Transport of Thyrotropin Releasing Hormone Across Excised Nude Mouse SkinJournal of Pharmaceutical Sciences, 1986